Revenue and EPS both better than same quarter last year. Good result.
If you just compare with last quarter, you need to learn harder about value in stocks.
EPS is to gauge the expensiveness. ROE is to gauge the efficiency of management. Revenue is to gauge the business activities.
Don't use trailing PE. Trailing PE is for past record and nothing to do with the future. Use forward PE instead. Forward PE is a guess. You can use Revenue and ROE to predict.
@laychee Most ppl will use historical/trailing PE to estimate future PE when you don't. You must be really good at forecasting future earning when using forward PE
If government gives free Vaccine to all Malaysian.. so there will name pharma company to takeover fill & finish of Vaccine & vaccine distribution contract. so Pharmaniaga and Duopharma stand good chance to award the contract.
Earning a bit disappointment. The indonesia losses probably due to their mco. Profit margin still not as high as I expected. However next 2 quarters should be better than previous year, even more so once vaccines are available. Can buy on weakness later
The Logistics and Distribution Division turned in a higher PBT of RM37 million for the first six months, up by 96% compared with RM19 million in the same period last year. This was driven by improved contributions from the non-concession business.
The Manufacturing Division posted a PBT of RM13 million on the back of a revenue of RM137 million, in line with order trends from Government hospitals. The outlook remains positive for the Division, with new product launches in the pipeline. In addition, further expansion into overseas markets, as well as increased capacity utilisation via its contract manufacturing business will be pursued by the Group.
The Indonesia Division recorded a deficit of RM2 million. This was mainly attributable to higher finance costs as a result of the delay in payments from government hospitals currently affecting Indonesia’s healthcare industry. The Division was further impacted by Indonesia’s large-scale social restrictions Pembatasan Sosial Berskala Besar in response to the Covid-19 pandemic, which resulted in limited access to doctors, clinics, pharmacies and hospitals.
Tend to hv more n more news abt vaccine towards year end. Hence Pharma n dpharma will again react opposite direction against the glove counter. I believe the support wd be strong before it can break nxt resistance.
The main logistic distribution profit double up which is clearly benefits from the covid 19. But due to MCO also, manufacturing earning drag down overall profit.
PS: please sell your shares to me. Foresee next qr will be much much better than 2019.
Pharma and dpharma is the first stock I see limit up. History will repeat.
Relax guys, this kind of project shall be open tendered, not like you buy sayur at pasar. The government shall handle the vaccination process in order to impose a certain price control for equality so that every citizen gets the same benefit.
In order to process biotechnology esp stuff like vaccine, you must have 3 criteria, 1. GMD license. 2. NPRA license. 3. Halal certification. As far as I know, Solution group have none of these.
Cansino already pick Solution, look at the announcement carefully it mentioned Solution the distributor.
If Solution has none of this why CANSINO pick solution ?
Posted by GuanYinMa > Aug 20, 2020 4:24 PM | Report Abuse
Relax guys, this kind of project shall be open tendered, not like you buy sayur at pasar. The government shall handle the vaccination process in order to impose a certain price control for equality so that every citizen gets the same benefit.
In order to process biotechnology esp stuff like vaccine, you must have 3 criteria, 1. GMD license. 2. NPRA license. 3. Halal certification. As far as I know, Solution group have none of these.
The last week SOLUTION share price has not really pick up, if you manage to collect Solution at below 30 sen right in the morning tomorrow you are consider very lucky.
This Solution share price still worthwhile to chase tomorrow.
Cansino already pick Solution, look at the announcement carefully it mentioned Solution the distributor.
If Solution has none of this why CANSINO pick solution ?
The last week SOLUTION share price has not really pick up, if you manage to collect Solution at below 30 sen right in the morning tomorrow you are consider very lucky.
This Solution share price still worthwhile to chase tomorrow.
Posted by GuanYinMa > Aug 20, 2020 4:24 PM | Report Abuse
Relax guys, this kind of project shall be open tendered, not like you buy sayur at pasar. The government shall handle the vaccination process in order to impose a certain price control for equality so that every citizen gets the same benefit.
In order to process biotechnology esp stuff like vaccine, you must have 3 criteria, 1. GMD license. 2. NPRA license. 3. Halal certification. As far as I know, Solution group have none of these.
The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that SGB had on 3 August 2020 entered into a Memorandum of Understanding (“MOU”) with CanSino Biologics Inc. (“CanSinoBIO”, SHSE: 688185, HKEX:06185).
The Company and CanSinoBIO have mutual interest in Collaboration on the potential COVID-19 vaccine co-developed by CanSinoBIO (“Projects”) and the Beijing Institute of Biotechnology, Academy of Military Medical Sciences (BIB). Further the relationship by discussing projects of mutual interest, with the possibility of a larger agreements for development, manufacturing and commercialization. It is understood that each party would contribute to these projects through scientific and product manufacturing know how, and that manufacturing would likely be undertaken by CanSinoBIO. SGB and CanSinoBIO hereinafter individually referred to as the “Party” or collectively as “the Parties”.
Duties and Responsibilities of the Parties 3.2.1 SGB shall perform the following: • Fill and finish of bulk COVID-19 vaccine supplied by CanSinoBIO. • Marketing and distribution in Malaysia.
Most likely the vaccine distribution will go thru tender process. Company need GDP and NPRA certified. Need GMP if to do any part of manufacturing process. Normally very long time and approval process to get yr facility assessed and approved by NPRA and ministry. Not for company who just had MOU of bla bla bla. Advantage is for company with ready facilities. Further govt has not decided which one to buy.
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
MQ Trader 684 views | 3 d ago
0:17
New IPO: An enterprise IT solutions provider that provides implementation services, maintenance, support and professional services, Vetece Holdings Bhd aims to list on the Ace Market!
MQ Trader 665 views | 7 d ago
0:17
New IPO: A manufacturing and trading of biomass fuel products, particularly PKS and wood pellets company, Elridge Energy Holdings Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Mashoh95
272 posts
Posted by Mashoh95 > 2020-08-19 18:21 | Report Abuse
I like duopharma management better, the CEO keep promote their company on news